Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde Cholangiopancreatography
- 26 September 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (13), 919-923
- https://doi.org/10.1056/nejm199609263351302
Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) is associated with elevated levels of pancreatic enzymes and pancreatitis. Gabexate, a protease inhibitor, has been used to prevent pancreatic damage related to ERCP.Keywords
This publication has 22 references indexed in Scilit:
- The Use of a Long-Acting Somatostatin Analogue (Octreotide) for Prophylaxis of Acute Pancreatitis after Endoscopic SphincterotomyEndoscopy, 1994
- Post-ERCP pancreatitis: Randomized, prospective study comparing a low- and high-osmolality contrast agentGastrointestinal Endoscopy, 1994
- Prospective Randomized Trial of the Effect of Nifedipine on Pancreatic Irritation after Endoscopic Retrograde CholangiopancreatographyDigestion, 1993
- Pancreatic duct obstruction in rabbits causes digestive zymogen and lysosomal enzyme colocalization.Journal of Clinical Investigation, 1989
- Prevention of Pancreatic Reactions by Bolus Somatostatin Administration in Patients Undergoing Endoscopic Retrograde Cholangio-Pancreatography and Endoscopic SphincterotomyHormone Research, 1988
- Gabexate Mesilate (FOY) Protects Against Ceruletide-Induced Acute Pancreatitis in the RatPancreas, 1987
- Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography.Gut, 1976
- Prospective Study for the Prevention of Pancreatitis Following Endoscopic Retrograde Cholangio-Pancreatography (ERCP)Endoscopy, 1975
- The role of glucagon in endoscopic cholangiopancreatographyGastrointestinal Endoscopy, 1975
- Post-endoscopy pancreatitis and hyperamylasuriaGastrointestinal Endoscopy, 1973